Subscribe to our Newsletters !!


    An antibody restricts infection by the SARS-CoV-2 in cells, researchers find

    Specialists at Utrecht University, Erasmus Medical Center and Harbor BioMed (HBM) today announced that they have recognized a completely human monoclonal antibody that forestalls the SARS-CoV-2 (COVID-19) virus from infecting cultured cells. The disclosure, distributed online today in Nature Communications, is an underlying advance towards building up a completely human immune response to treat or

    China shrouded infection’s seriousness to store supplies: Report

    US authorities trust China concealed the degree of the coronavirus flare-up — and how infectious the ailment is — to load up on clinical supplies expected to react to it, knowledge records appear. Chinese pioneers “deliberately covered the seriousness” of the pandemic from the world toward the beginning of January, as per a four-page Department

    Pfizer, BioNTech start human coronavirus antibody preliminary in US

    Pfizer Inc and BioNTech SE said on Tuesday they have started conveying dosages of their trial coronavirus antibodies for beginning human testing in the United States. The U.S. drugmaker and German accomplice said if the antibody ends up being protected and successful in preliminaries, it might be prepared for wide U.S. dissemination before the year’s

    WHO cautions against surged end to coronavirus lockdowns

    The World Health Organization (WHO) cautioned on Wednesday that nations rising up out of limitations to stop the new coronavirus must continue “incredibly cautiously” or hazard a quick ascent in new cases. Chief General Tedros Adhanom Ghebreyesus said nations expected to guarantee they had sufficient measures to control the spread of the COVID-19 respiratory illness

    Absence of clinical speculation,medicinal services framework huge difficulties for India’s COVID-19 battle: Fitch

    Notwithstanding extra subsidizing, the proceeded with absence of clinical speculation and medicinal services framework will introduce difficulties to mounting a powerful reaction in India against COVID-19 pandemic, Fitch Solutions has said. “The proceeded with absence of clinical financing and human services framework educate our view for the potential scourge to be more terrible in India

    ‘This infection may never leave’: WHO cautions as new groups rise

    New coronavirus groups have surfaced far and wide as countries battle to adjust reviving economies and forestalling a second flood of contaminations, while a top worldwide wellbeing official cautioned Wednesday that COVID-19 could be around for quite a while. Experts in the Chinese city of Wuhan, where the pandemic initially started toward the end of

    India bolsters move at WHO to look for beginning of coronavirus

    India is relied upon to join more than 60 nations at a two-day essential gathering of the World Health Organization in Geneva in pushing for an “unprejudiced, free and exhaustive” assessment of the worldwide reaction system to the COVID-19 emergency just as to discover the “zoonotic source” of the savage disease. The two-day 73rd meeting

    WHO bows to calls from nations for free coronavirus test

    The World Health Organization bowed to calls Monday from the greater part of its part states to dispatch a free test into how it dealt with the universal reaction to the coronavirus, which has been blurred by blame dispensing between the U.S. what’s more, China over a pandemic that has murdered more than 300,000 individuals

    WHO stops preliminary of hydroxychloroquine in COVID-19 patients because of security concerns

    The World Health Organization has suspended testing the intestinal sickness tranquilize hydroxychloroquine in COVID-19 patients because of security concerns, WHO Director General Tedros Adhanom Ghebreyesus said on Monday. Hydroxycholoroquine has been touted by Donald Trump and others as a potential treatment for the ailment brought about by the novel coronavirus. The U.S. President has said